Taro-Sunitinib 25 mg (Sunitinib (Sunitinib Malate) CAPSULE) 25 MG

Taro-Sunitinib 25 mg capsules are a prescription medication used to treat certain types of cancer. This oral medication contains sunitinib malate, a tyrosine kinase inhibitor. Learn more about its uses and effects.

Strength

25 MG

Manufacturer / TM Owner

TARO PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Taro-Sunitinib 25 mg capsules are primarily used in the treatment of specific cancers, such as renal cell carcinoma and gastrointestinal stromal tumors. Sunitinib malate, the active ingredient, works by inhibiting certain proteins that help cancer cells grow. This medication is often prescribed when other treatments have not been effective. Always consult a healthcare provider to determine if this medication is suitable for your condition.

Side Effects

Common effects of Taro-Sunitinib 25 mg capsules may include fatigue, nausea, and diarrhea. Some individuals may also experience changes in taste, hair color, or skin discoloration. These effects can vary in severity and duration. If you experience any severe or persistent side effects, it is important to seek medical advice.

Precautions & Warnings

Taro-Sunitinib 25 mg capsules should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the capsules out of reach of children and pets. Always follow the instructions provided by your healthcare provider regarding the administration and storage of this medication.

Avoid Interactions

Taro-Sunitinib 25 mg capsules may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and herbal supplements. Avoid consuming grapefruit or grapefruit juice, as it can affect the metabolism of sunitinib malate.

Frequently Asked Questions

Taro-Sunitinib 25 mg capsules are used to treat certain types of cancer, such as renal cell carcinoma and gastrointestinal stromal tumors.

Store Taro-Sunitinib 25 mg capsules in a cool, dry place away from direct sunlight and keep them out of reach of children and pets.

Common effects may include fatigue, nausea, diarrhea, changes in taste, hair color, or skin discoloration.

Taro-Sunitinib 25 mg may interact with certain medications, so it is important to consult your healthcare provider before combining it with other drugs.

The safety of Taro-Sunitinib 25 mg during pregnancy has not been established. Consult your healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.